HomeNOVKAN • STO
add
Novakand Pharma AB
Previous close
kr 0.15
Day range
kr 0.15 - kr 0.16
Year range
kr 0.13 - kr 0.34
Market cap
19.23M SEK
Avg Volume
439.16K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.13M | -55.38% |
Net income | -23.08M | -108.68% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.27M | -61.56% |
Total assets | 23.19M | -70.09% |
Total liabilities | 3.16M | -43.43% |
Total equity | 20.03M | — |
Shares outstanding | 121.19M | — |
Price to book | 0.90 | — |
Return on assets | -36.71% | — |
Return on capital | -40.63% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -23.08M | -108.68% |
Cash from operations | -5.33M | 70.00% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -5.33M | 70.00% |
Free cash flow | -3.45M | 75.19% |
About
Website
Employees
5
